The best ASX shares to research right now span three broad sectors: large-cap resources and financials for stability, healthcare and technology for long-term growth, and selective smaller names where conviction and patience can pay off handsomely. No single list suits every investor — but understanding why these companies stand out gives you a sharper framework for building your own watchlist.

General information only. This article does not constitute financial advice. Consider your own circumstances before making investment decisions.

Why the ASX Rewards Patient Research

The ASX 200 is heavily concentrated, with the top 10 companies making up roughly 45% of total index weight as of mid-2026. That concentration cuts both ways: it means a handful of names drive the market, and if you understand those businesses deeply, you have covered a lot of ground.

Australia’s franking credit system is also genuinely unique. Many ASX-listed companies pay fully or partially franked dividends, which means the tax paid at the company level is passed on to shareholders as a credit. For investors on a marginal rate below 30%, this can actually result in a tax refund — a real advantage that offshore markets simply don’t offer.

Blue-Chip ASX Shares Worth Studying

BHP Group (ASX: BHP) is the most logical starting point for any new investor. It’s the world’s largest diversified miner by market cap, with major exposure to iron ore, copper, and coal. In FY2025, BHP produced around 260 million tonnes of iron ore from the Pilbara — a scale that is effectively impossible to replicate. The copper portfolio, particularly through the Escondida mine in Chile, positions BHP well as global electricity infrastructure spending accelerates.

Commonwealth Bank (ASX: CBA) trades at a significant premium to the other Big Four banks and has done so consistently for over a decade. That premium reflects genuine quality: CBA has the highest return on equity of any major Australian bank (around 14–15%), the strongest digital platform, and a retail deposit base that keeps funding costs low. Critics say it’s always overvalued; supporters note they’ve been saying the same thing for 20 years while the share price kept climbing.

CSL Limited (ASX: CSL) is one of the few genuinely world-class companies on the ASX. Its plasma collection and fractionation business dominates globally, and the acquisition of Swiss pharma company Vifor expanded its reach into iron deficiency and kidney disease treatment. CSL reinvests aggressively — R&D spending exceeds $1.4 billion USD annually — which keeps the pipeline full and the competitive moat wide.

Growth-Oriented ASX Shares to Watch

Xero (ASX: XRO) is Australia’s most successful software company by any meaningful measure. Its cloud accounting platform serves over 4.2 million subscribers globally, with particular strength in Australia, New Zealand, and the UK. What makes Xero worth researching is its operating leverage: revenue per subscriber has been rising steadily while infrastructure costs scale slowly, meaning incremental growth increasingly falls to the bottom line.

Wesfarmers (ASX: WES) doesn’t get enough credit as a growth business. Beyond the Bunnings hardware empire — which generates roughly $2.2 billion in EBIT annually — Wesfarmers has been quietly building positions in lithium (through the Mt Holland project), health and wellness retail via API (Priceline’s parent), and data analytics. It’s a diversified conglomerate run by one of the best capital allocation teams in the country.

What to Look for When Researching ASX Shares

Three things matter more than anything else when evaluating ASX companies:

  1. Return on equity (ROE) over 10+ years — consistent ROE above 15% is rare and tells you the business genuinely creates value rather than just growing revenue
  2. Free cash flow conversion — profit is an opinion, cash is a fact; look for companies that convert more than 80% of net profit into free cash flow
  3. Competitive position — ask whether the company would still be dominant in 10 years if a well-funded competitor attacked its market directly

Tools like CommSec, Selfwealth, and the ASX’s own company announcements platform (asx.com.au) give you access to annual reports, investor presentations, and half-year results for every listed company at no cost.

Frequently Asked Questions

What is the best ASX share to buy right now?

There’s no single correct answer — it depends on your time horizon, risk tolerance, and existing portfolio. That said, BHP, CBA, and CSL are the three most commonly researched blue-chip names among Australian retail investors due to their scale, franking credits, and long performance histories.

How do I start investing in ASX shares?

You’ll need a brokerage account with an Australian platform such as CommSec, Selfwealth, or Stake. Most accounts can be opened online in under 10 minutes. Brokerage fees typically range from $5 to $19.95 per trade depending on the platform and order size.

Are ASX shares a good investment in 2026?

The ASX has delivered an average annual total return of around 9–10% over the past 30 years including dividends and franking credits. Past performance doesn’t guarantee future results, but Australian equities remain a core holding in most long-term portfolios due to the income advantages of the franking system.

Sharpen your investing knowledge with the right books — from Warren Buffett biographies to Australian-specific guides on ASX investing and dividend strategies.

Browse Investing Books on Amazon AU →